Introduction
CLA exerts several positive activities including fat reducing, immune system modulation, and anti-inflammatory effect (1) (2) (3) (4) (5) . CLA can reduce chronic inflammation and decrease antigen-induced cytokine production in immuno-competent cells. In addition, CLA can modulate production of cytokines, prostaglandins, and leukotrien B4 (6) (7) (8) and can improve immune responses by affecting production of tumor necrosis factor-α (TNFα), the cytokines interleukin (IL)-1, IL-4, IL-6, and IL-8, prostaglandins, and nitric oxides while reducing allergic immune responses (6, 9, 10 ).
An indirect influence of dietary trans vaccenic acid (TVA) on immune functions or inflammation in humans has been described previously. Tholstrup et al. (11) found no difference in serum creactive protein (CRP) concentrations when comparing subjects consuming diets containing high and low TVA levels for 5 weeks. Kuhnt et al. (12) measured a number of immune and inflammatory parameters in 24 healthy subjects consuming a diet containing equal amounts of TVA and trans-12 C18:1, or a diet without CLA and trans fatty acids for 6 weeks and reported that plasma levels of the inflammation markers IL-6, IL-8, TNFα, and CRP, the phagocytic function, and circulating immune cell phenotypes did not significantly differ between the diet groups. In addition to short term feeding studies using JCR-LA cp/cp rats, Wang et al. (13) reported that consumption of a TVA-enriched diet (1.0%, w/w) for 16 weeks significantly improved reduced ex vivo IL-2 production of splenocytes caused by phorbol myristate acetate and ionomycin stimulation. Production of IL-2 in response to the mitogen (phorbol myristate acetate and ionomycin) with a function of stimulating immune cells via intracellular mechanisms was normalized to levels in cells from obese JCR rats, demonstrating that consumption of TVA for long periods of time can influence immune responses under immunosuppressive conditions. Although there is an association between TVA intake and beneficial effects with reduced disease factors, further studies are needed to study the beneficial effect of TVA concentrations and consumption times to understand the impact of TVA on human health. Therefore, the objective of this study was to evaluate the direct influences of trans-11 18:1 TVA as a dietary factor on cell growth and cytokine production of leukocytes isolated from the mouse spleen, and associated cytotoxicity.
Materials and Methods
Preparation of TVA, c9, t11-CLA, and elaidic acid Five hundred µmol of fatty acid-free bovine serum albumin (BSA) (Sigma-Aldrich, St. Louis, MO, USA) dissolved in phosphate-buffered saline (PBS) was filtered through a 0.22-µm membrane (MN sterilizer PES) (MachereyNagel GmbH Co., Duren, Germany). Elaidic acid (EA) (Matreya LLC, Pleasant Gap, PA, USA), TVA (Matreya LLC), and c9, t11-CLA (Matreya LLC) were dissolved in PBS containing 50-200 µM BSA, mixed gently with vortexing (Vortex-Genie Animals and diet Imprinting Control Region (ICR) 6 week old male mice (Japan SLC Inc., Shizuoka, Japan) were acclimated for 7 days prior to a health status evaluation. Mice were individually housed with sawdust bedding and maintained in a temperature-controlled room (22±2 o C) with 50±10% relative humidity under a 12 h photoperiod (lights on from 08:00 to 20:00 h) with free access to drinking water and chow throughout the experimental period. This study was authorized and undertaken in accordance with ethics requirements of the Official Ethical Committee of Pusan National University (PNU 2012-0056), and all institutional and national guidelines for the care and use of laboratory animals were followed.
Isolation of splenocytes from the mouse spleen Leukocytes were collected from the spleen of ICR mice as previously described by Lee et al. (14) . Briefly, after an acclimation period, animals were sacrificed under CO 2 gas anesthesia. The spleen of each mouse was aseptically removed and placed in a 15 mL tube containing complete Rosewell Park Memorial Institute (RPMI) 1640 medium containing RPMI 1640 medium (Thermo Fisher Scientific Inc., Waltham, MA, USA) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS) (Thermo Fisher Scientific) and a 1% (v/v) penicillin-streptomycin solution (Thermo Fisher Scientific). The removed spleen was cut into small pieces and placed in a glass homogenizer with complete RPMI 1640 medium. Each cell suspension was then passed through a cell strainer Determination of the number of viable splenocytes in response to fatty acids The number of viable cells was measured using a cell counting kit-8 (Dojindo, Kumamoto, Japan) as previously described by Park et al. (15) . Isolated splenocytes were seeded at a density of 5×10 3 cells/well into 96 well plates (Corning Inc., Lowell, MA, USA) and exposed to 50-200 µM fatty acids and incubated (IR Sensor MCO-17A1; Sanyo Electric Biomedical Co., Ltd, Osaka, Japan) for 2 h at 37 o C in a humidified atmosphere with 95% air and 5% CO 2 . After incubation, cells were exposed to 10 µL of a WST-8 [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt] solution and incubated (IR Sensor MCO-17A1; Sanyo Electric Biomedical Co., Ltd) for 3, 12, 24, 48, and 72 h at 37 o C in a humidified atmosphere with 95% air and 5% CO 2 . The optical density of each well was measured at 450 nm using a Multiskan EX Microplate Reader (Thermo Fisher Scientific).
Distribution of Annexin V and Propidium iodide-incorporation in cells exposed to fatty acids The potential cytotoxicity of EA, TVA, and c9, t11-CLA to splenocytes was measured using Annexin V Incubation Reagent (TACS Annexic V Kit; Trevigen Inc., Gaithersburg, MD, USA) as previously described by Park et al. (16) . Briefly, freshly isolated splenocytes were seeded at a density of 5×10 5 cells/500 µL into a 1.5 mL tube. Cells were then exposed to 50-200 µM fatty acids and incubated (IR Sensor MCO-17A1; Sanyo Electric Biomedical Co., Ltd.) at 37 o C for 3 or 24 h in a humidified atmosphere with 95% air and 5% CO 2 . After incubation, cells were centrifuged (Combi 514R; Hanil Science Industrial Corp.) at 300×g for 5 min at room temperature, washed once in 4 o C PBS, and treated with 100 µL of Annexin V Incubation Reagent (TACS Annexic V Kit; Trevigen) and 50 µL of propidium iodide (PI) per sample (1×10 5 cells). The resulting mixture was incubated (IR Sensor MCO-17A1; Sanyo Electric Biomedical Co., Ltd.) in the dark for 15 min at room temperature, added 400 µL of 1x binding buffer (TACS) (Annexic V Kit; Trevigen), and subjected to flow sorting with FACSCalibur (Becton; Dickson and Company) within 1 h to obtain a maximal signal. Data (10,000 total events) were analyzed using FlowJo (version 7.2.5; TreeStar Inc., Ashland, OR, USA).
Cytokine production in response to fatty acids Anti-mouse TNFα, IFNγ, and IL-10 ELISA kits (eBioscience, San Diego, CA, USA) were used. Cytokine concentrations in the culture supernatant were evaluated according to manufacturer instructions. Briefly, production of cytokines was determined using ELISA (eBioscience) at 24 h after co-culture of splenocytes isolated from the mouse spleen with fatty acids followed by challenges with and without 10 ng/mL lipopolisaccharides (LPS) of Escherichia coli 0111:B4 (Sigma-Aldrich).
Statistical analysis All data were expressed as means±standard error (SE). Comparisons of multiple groups were analyzed using a one-way analysis of variance (ANOVA) based on Duncan's test (Fig. 1) and Tukey Kramer test (Fig. 2-4 ). Differences were considered as statistically significant at p<0.05. All analyses were performed using SPSS 11.5 software (SPSS Inc., Chicago, IL, USA).
Results and Discussion
Physiological concentrations of CLA in human sera are in the range of 10-70 µM (17). However, levels up to 5x higher than normal sera levels of CLA have been reported in humans following long term supplementation with CLA (18), indicating that 50-200 µM concentrations of CLA (including TVA used in this study) also corresponds to physiological levels. CLA can exert a direct anti-carcinogenic effect in MCF-7 cells (19) . Therefore, proliferation of isolated splenocytes treated with different concentrations of EA, TVA, and c9, t11-CLA for 3 to 72 h was measured (Fig. 1) . The number of splenocytes incubated with 50 µM EA was not significantly (p>0.05) different, compared to control cells (BSA). However, EA promoted proliferation of splenocytes at a concentration of 100 µM for 12 and 24 h and at 200 µM for 3, 12, and 72 h.
The number of splenocytes was measured after exposure to 50, 100, and 200 µM TVA. The number of splenocytes incubated with TVA at concentrations of 50 µM for 3, 12, and 72 h with TVA at 100 µM for 12 h was significantly (p<0.05) increased, compared with controls. The number of splenocytes incubated with 200 µM TVA for 3, 12, and 72 h was also significantly (p<0.05) increased, compared with controls. On the other hand, the number of splenocytes incubated with TVA at concentrations of 100 µM for 24 h was significantly (p<0.05) decreased, compared with controls. Treatment with c9, t11-CLA at a concentration of 50 µM for 3, 12, and 72 h and at 200 µM for 3 and 12 h significantly (p<0.05) increased the number of splenocytes, compared with controls. However, c9, t11-CLA at a concentration of 100 µM for 24 h of incubation induced a significant (p<0.05) reduction in cell proliferation, compared with controls.
A previous study demonstrated that TVA does not reduce immune cell viability (20) . This study showed that Jurkat T-cells incubated with butter fat at 0.8 or 1.7 mg/mL, or synthetic rumenic acid, alphalinolenic acid, and linoleic acid at concentrations from 15-130 mM, resulted in a dose-dependent decrease in cell growth, with TVA as the only exception. In this study, TVA treatment for 3, 12, and 72 h promoted growth of immune cells isolated from the mouse spleen at all concentrations tested, except for 100 µM.
The ability of EA, TVA, and c9, t11-CLA to induce apoptosis was determined using an Annexin-V Apoptosis Detection Kit (TACS Annexic V Kit; Trevigen Inc.). Percentages of cells in stages of necrosis, early apoptosis, and late apoptosis were analyzed. Within 3 h of incubation, both EA and c9, t11-CLA failed to induce necrosis or apoptosis (Fig. 2) . However, TVA at concentrations of 50 and 100 µM significantly (p<0.05) induced apoptosis in PI + Annexin V + cells (late apoptotic cells), compared with control cells (BSA treatment). Flow cytometry revealed that splenocytes co-cultured with EA at 50 and 200 µM for 24 h significantly (p<0.05) induced late apoptosis in splenocytes, compared with control cells. However, TVA at any concentration failed to promote induction of necrosis or apoptosis, compared with control cells (BSA). Previous study has shown that t9-c18:1 EA can induce apoptosis in human umbilical vein endothelial cells in a dose-dependent manner (21) . In addition, mRNA expression and activities of caspases 8, 9 and 3 were significantly increased by t9-c18:1 EA (21). A study by Keating et al. (22) has shown that increased levels of both CLA isomers have negative impacts on cell growth and significantly reduced cell numbers at concentrations of 35 µM and above (22) . In addition, increased levels of both CLA isomers can cause a 2x increase in induction of mammary cell apoptosis (22) . In this study, apoptosis was significantly (p<0.05) promoted after 3 h of cultivation with TVA and 24 h of cultivation with EA, compared with control cells (BSA). However, cultivation with c9, t11-CLA had no effect on apoptosis.
Different effects on immune cells by the 3 fatty acids might be due to different cell types used and different underlying apoptosis mechanisms. In general, the balance between cell proliferation and death is closely related to the cell cycle to maintain an appropriate number of cells in tissue, referred to as homeostasis. In this study, TVA at 50-200 µM promoted both proliferation and apoptosis of immune cells isolated from the normal mouse spleen ( Fig. 1 and 2) . Additionally, a previous study reported that TVA at 50-200 µM had a direct anti-carcinogenic effect on MCF-7 cells (19) . TVA within physiological levels can probably control activation or inhibition of the cell cycle via extracellular signals. Further study is required to understand the precise mechanism of cell cycle control in response to TVA.
Production of TNFα, IFNγ, and IL-10 by splenocytes in response to EA, TVA, and c9, t11-CLA is shown in Fig. 3 . EA stimulated production of almost all tested cytokines in splenocytes, except IFNγ, after exposure to EA at concentrations of 100 and 200 µM. Production of TNFα was stimulated in splenocytes after treatment with c9, t11-CLA at all concentrations tested. However, production of IFNγ in splenocytes exposed to c9, t11-CLA was significantly (p<0.05) reduced, compared with control cells (BSA). In addition, production of TNFα, IFNγ, and IL-10 in splenocytes was significantly (p<0.05) increased by TVA at a concentration of 100 µM, with control cells (BSA). TVA at a concentration of 100 µM promoted more cytokine production in splenocytes than EA, c9 and t11-CLA at all concentrations, and more than TVA at other concentrations (50 and 200 µM). Thus, TVA, EA, and c9, t11-CLA stimulated production of cytokines in splenocytes. In particular, TVA at 100 µM significantly (p<0.05) increased cytokine production, compared with control cells (BSA).
It has been reported that splenocytes from TVA-fed rats had 16-23% lower production levels of IL-2, IL-10, and TNFα without any significant difference in the concentrations of IFNγ or IL-6 after ConA stimulation (23) . In addition, consumption of a TVA-enriched diet (10%, w/w) for 16 weeks significantly improved reduced ex vivo proliferative responses, based on IL production, in splenocytes stimulated with phorbol myristate acetate and ionomycin (13) . Production of IL-2 in response to a mitogen (phorbol myristate acetate and ionomycin) that stimulated immune cells via intracellular mechanisms was normalized in cells from obese JCR rats (13) . Thus, consumption of vaccenic acid for long periods can influence immune responses under immunosuppressive conditions. A concentration of 100 µM TVA was found to have immunomodulation effects while other concentrations might have negative effects, or no effects.
Concentrations of TNFα, IFNγ, and IL-10 generated by LPSchallenged splenocytes in LPS challenge experiments were significantly (p<0.05) higher than from splenocytes not exposed to LPS (Fig. 4) . Concentrations of TNFα in LPS-challenged splenocytes treated with 100 µM TVA or c9, t11-CLA were significantly (p<0.05) lower than in LPS-challenged splenocytes incubated with BSA. In addition, levels of IFNγ generated in LPS-challenged splenocytes incubated with TVA at 50 and 200 µM, EA at 200 µM, and c9, t11-CLA at 100 and 200 µM, were significantly (p<0.05) lower than in LPS-challenged splenocytes exposed to BSA. Production of IL-10 in LPS-challenged splenocytes treated with 100 µM c9, t11-CLA was significantly (p<0.05) lower than production in LPS-challenged splenocytes incubated with BSA. Thus, TVA, a precursor of c9, t11-CLA, and c9, t11-CLA in mouse splenocytes can suppress the inflammation response in LPSchallenged splenocytes and inhibit synthesis of pro-inflammatory cytokines.
Yang and Cook (10) have shown that c9, t11-CLA can decrease TNFα production in RAW macrophage cells. LPS-induced anorexia and cachexia were also ameliorated in CLA-fed animals (10). Moreover, increases in plasma TNFα levels after LPS injection were also suppressed in CLA-fed mice (10) . When pigs were injected with LPS, each CLA isomer was found to suppress production and expression of IL-1β, IL-6, and TNFα while enhancing PPARγ activation and gene expression (7) .
Verification testing has been performed for the immune-modulation effect of c9, t11-CLA. However, there is limited information available on TVA function. Only one study by Blewett et al. (23) reported that TVA had no effect on cytokine production in splenic and mesenteric lymph node cells from lean rats after mitogenic stimulation, although lower concentrations of IL-10 secreted by splenocytes stimulated with LPS were observed. In this study, physiological concentrations of TVA at 50, 100, and 200 µM in mice following long-term supplementation suppressed production of TNFα in splenocytes after LPS challenge. Cytokines modulated by TVA influenced homeostasis and immune surveillance in a host immune system (7, 10) .
In conclusion, TVA at 50-200 µM induced immune-modulation. Other concentrations of this compound may have negative consequences or have no effects. The amount of IL-10 produced by splenocytes treated with 200 µM TVA was increased. Nevertheless, any concentration of TVA might have undesirable effects. Large quantities of TVA may cause allergic reactions. Physiological levels of TVA in mouse splenocytes after long term exposure can reduce production of pro-inflammatory cytokines during acute inflammation. Further in vitro and in vivo studies will allow better understanding of the precise influence of trans fatty acids on production of proinflammatory markers under acute inflammation conditions. p<0.05 compared with a value without fatty acids (BSA).
